Eli Lilly

Developing brand-new drugs is a long and expensive process that doesn't always deliver a positive return on investment. Occasionally, some pharmaceutical compan...

Friday, June 14, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on...

CONCORD, N.C. — Eli Lilly (LLY) unveiled its newest manufacturing plant in Concord, N.C., Friday, which the company says will help relieve manufacturing bottlen...

David Ricks, the CEO of Mounjaro and Zepbound maker Eli Lilly, says that food, diet, and fitness companies have called him for advice regarding the growing popu...

GLP-1 weight-loss drugs have been major revenue generators for pharmaceutical companies such as Eli Lilly (LLY) and Novo Nordisk (NVO). Goldman Sachs US Lead Bi...

For Immediate Releases Chicago, IL – June 13, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...

Novo Nordisk's (NYSE: NVO) Wegovy currently reigns as the king of the obesity drug market. It generated roughly $4.5 billion in sales last year and will likely...

For Immediate Release Chicago, IL – June 14, 2024 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey wi...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing style...

When it comes to the stock market, winners tend to keep winning. That's a core tenet that many investors at The Motley Fool ascribe to. Here are two proven weal...